# Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

> **NCT00043927** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 760 (—)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** topotecan/cisplatin
- **DRUG:** etoposide/cisplatin

## Key facts

- **NCT ID:** NCT00043927
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2004-01
- **Final completion:** —
- **Target enrollment:** 760 (—)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043927, "Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00043927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*